T 0289/10 (Human growth hormone aqueous formulation/Genentech, Inc.) of 13.03.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T028910.20140313
- Date of decision
- 13 March 2014
- Case number
- T 0289/10
- Petition for review of
- -
- Application number
- 99107148.1
- IPC class
- A61K 38/27A61K 47/26A61K 47/10
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Human growth hormone aqueous formulation
- Applicant name
- Genentech, Inc.
- Opponent name
- Novo Nordisk A/S
PFIZER LIMITED
Sandoz GmbH - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)
- Keywords
- Sufficiency of disclosure (no)
- Catchword
- -
- Cited cases
- G 0001/03
- Citing cases
- -
Order
For these reasons it is decided that:
1.The decision under appeal is set aside
2. The patent is revoked.